Department of Biochemistry and Biotechnology, Faculty of Agriculture, Kagoshima University, Kagoshima 890-0065, Japan.
Expert Opin Drug Deliv. 2010 Oct;7(10):1145-58. doi: 10.1517/17425247.2010.515208.
Antibiotic resistance is a serious problem that continues to challenge the healthcare sectors and has become increasingly alarming in the past few years. To face this emerging global crisis, there is a need to find a new class of antibiotics that act on new microbial targets and/or harness existing antibiotics by developing new drug-targeting strategies.
This review: explores an innovative drug-delivery strategy of using hen egg lysozyme as a carrier to enable water solubilization and to allow specific targeting to the microbial cells of a water-insoluble antimicrobial agent with a powerful killing action; addresses potentials for lysozyme in antibiotics drug targeting; and provides insight for the future direction of this highly prospective technology.
The unique features and advantages of lysozyme-based drug delivery system are highlighted. The efficiency of lysozyme in solubilization and delivery of lipophilic antibiotics, to reformulate drugs that may fail clinical trials owing to low solubility, is emphasized.
Fewer pharmaceutical companies are inventing new antibiotics because of long development times and high failure rates. Combining lysozyme with a powerful old antibiotic may open doors to revolutionizing medicine, particularly in the treatment of deadly infections.
抗生素耐药性是一个严重的问题,继续挑战医疗保健部门,并已成为越来越令人震惊的在过去几年中。面对这一新兴的全球危机,有必要找到一种新的抗生素类药物,对新的微生物靶标和/或利用现有的抗生素通过开发新的药物靶向策略。
探讨了一种创新的药物传递策略,使用鸡卵溶菌酶作为载体,使水不溶性抗菌剂具有强大的杀菌作用的水溶性和对微生物细胞的特异性靶向成为可能;讨论了溶菌酶在抗生素药物靶向中的潜力;并为这项极具前景的技术的未来发展方向提供了深入了解。
突出了基于溶菌酶的药物传递系统的独特特点和优势。强调了溶菌酶在增溶和递送脂溶性抗生素方面的效率,可重新配制因溶解度低而可能导致临床试验失败的药物。
由于开发时间长和失败率高,越来越少的制药公司在发明新的抗生素。将溶菌酶与一种强大的旧抗生素结合使用,可能为医学革命打开大门,特别是在治疗致命感染方面。